23 Jan Cellistic
Posted at 17:26h
in
Gustavo Mahler, Ph.D., CEO
April 16 | 11:15am | Salone dei Cavalieri, Section 2
(Private)
Cellistic specializes in process development and manufacture of immune cell therapies based on human induced pluripotent stem cell (iPSC) technology using their Pulse and Echo Platform. Its focus and expertise in iPSC reprogramming, gene editing and differentiation development positions the company to be the partner of choice for innovative cell therapy developers to advance into clinic. Leveraging more than a decade of scientific and technical knowledge and experience, Cellistic possesses unique capabilities for the design and optimization of proprietary manufacturing platforms for iPSC- based cell therapies.
